Literature DB >> 33593798

Mapping access to endovascular stroke care in the USA and implications for transport models.

Jared Aldstadt1, Muhammad Waqas2,3, Misa Yasumiishi1, Maxim Mokin4,5, Vincent M Tutino2,6, Hamid H Rai7, Felix Chin7, Bennett R Levy8, Ansaar T Rai9, J Mocco10, Kenneth V Snyder3,11, Jason M Davies3,12, Elad I Levy2,3, Adnan H Siddiqui13,3.   

Abstract

BACKGROUND: The purpose of this cross-sectional study was to determine the percentage of the US population with 60 min ground or air access to accredited or state-designated endovascular-capable stroke centers (ECCs) and non-endovascular capable stroke centers (NECCs) and the percentage of NECCs with an ECC within a 30 min drive.
METHODS: Stroke centers were identified and classified broadly as ECCs or NECCs. Geographic mapping of stroke centers was performed. The population was divided into census blocks, and their centroids were calculated. Fastest air and ground travel times from centroid to nearest ECC and NECC were estimated.
RESULTS: Overall, 49.6% of US residents had 60 min ground access to ECCs. Approximately 37.7% (113 million) lack 60 min ground or air access to ECCs. Approximately 84.4% have 60 min access to NECCs. Ground-only access was available to 77.9%. Approximately 738 NECCs (45.4%) had an ECC within a 30 min drive.
CONCLUSION: Nearly one-third of the US population lacks 60 min access to endovascular stroke care, but this is highly variable. Transport models and planning of additional centers should be tailored to each state depending on location and proximity of existing facilities. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  economics; statistics; stroke; technology; thrombectomy

Mesh:

Year:  2021        PMID: 33593798     DOI: 10.1136/neurintsurg-2020-016942

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  2 in total

Review 1.  Mechanical Thrombectomy Access for All? Challenges in Increasing Endovascular Treatment for Acute Ischemic Stroke in the United States.

Authors:  Sushanth Rao Aroor; Kaiz S Asif; Jennifer Potter-Vig; Arun Sharma; Bijoy K Menon; Violiza Inoa; Cynthia B Zevallos; Jose G Romano; Santiago Ortega-Gutierrez; Larry B Goldstein; Dileep R Yavagal
Journal:  J Stroke       Date:  2022-01-31       Impact factor: 6.967

2.  Quantifying the amount of greater brain ischemia protection time with pre-hospital vs. in-hospital neuroprotective agent start.

Authors:  Vartan Matossian; Sidney Starkman; Nerses Sanossian; Samuel Stratton; Marc Eckstein; Robin Conwit; David S Liebeskind; Latisha Sharma; May-Kim Tenser; Jeffrey L Saver
Journal:  Front Neurol       Date:  2022-09-13       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.